What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
On this page, you'll find all Sec Filings coverage from four recent articles, highlighting how filings influence stock moves and what it means for your portfolio.
112 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
When a hedge fund takes position in a logistics stock, it often signals confidence in the sector's growth prospects a...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As interest rates climb, even active managers recalibrate risk. Advocacy Wealth Management recently trimmed a major P...
Institutional moves can reshape a niche tech stock overnight. This article breaks down the recent liquidation by Loun...
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
BlackRock filed with the SEC on May 8 to launch two tokenized money market funds, including a digital class for BSTBL...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
A tiny $3.7 million exit can mask broader gains in regional bank stocks. This article breaks down what that signal re...